Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00080782
What this trial is testing

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 14
Not applicableLooking for participantsNCT01961713
What this trial is testing

Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 200
Not applicableUnknownNCT01089881
What this trial is testing

The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 150
Not applicableStudy completedNCT06883474
What this trial is testing

Osteosclerotic Changes on CT Predict Survival in Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease
Sun Yat-sen University 211
Testing effectiveness (Phase 2)Looking for participantsNCT06675357
What this trial is testing

Using FAPI PET/MRI to Evaluate Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic DiseaseProstate Cancers
University of Wisconsin, Madison 30
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Not applicableEnrolling By InvitationNCT07660276
What this trial is testing

AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology

Who this might be right for
Prostate Cancer Metastatic
Xiangya Hospital of Central South University 3,000
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Not applicableUnknownNCT02849522
What this trial is testing

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).

Who this might be right for
Lower Urinary Tract Symptoms Caused by Benign Prostatic Enlargement (LUTS BPE)Prostate Artery Embolisation (PAE)Transurethral Resection of the Prostate (TURP)+2 more
Cedar, United Kingdom 300
Large-scale testing (Phase 3)Study completedNCT01824342
What this trial is testing

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Amgen 18
Not applicableUnknownNCT03134261
What this trial is testing

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic to Bone
Herlev Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 219
Testing effectiveness (Phase 2)Ended earlyNCT01267266
What this trial is testing

Saracatinib in Treating Patients With Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)UnknownNCT04245566
What this trial is testing

Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH

Who this might be right for
Benign Prostatic HyperplasiaPharmacotherapyProstatic Artery Embolization+1 more
Dominik Abt 425
Not applicableUnknownNCT04177056
What this trial is testing

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

Who this might be right for
Bone MetastasesProstate CancerBreast Cancer+2 more
Hamilton Health Sciences Corporation 40
Testing effectiveness (Phase 2)Ended earlyNCT01097707
What this trial is testing

A Study in Men With Benign Prostatic Hyperplasia

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 414
Not applicableUnknownNCT01615965
What this trial is testing

Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Technical University of Munich 160
Not applicableStudy completedNCT01967862
What this trial is testing

Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
City of Hope Medical Center 54
Early research (Phase 1)Study completedNCT01347788
What this trial is testing

Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Massachusetts General Hospital 34
Next Page